{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:35:17Z","timestamp":1792254917654,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2020YFC2008305"],"award-info":[{"award-number":["2020YFC2008305"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11126-023-10018-x","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:16:12Z","timestamp":1679868972000},"page":"113-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["SSRI\/SNRI -induced Hyponatremia: A Case Series of 26 Patients in a Single Institution from 2018 to 2020"],"prefix":"10.1007","volume":"94","author":[{"given":"Zinan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"10018_CR1","doi-asserted-by":"crossref","unstructured":"Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry.\u00a01999;60(Suppl 4):4\u201311, 12\u201313.","DOI":"10.4088\/JCP.v60n1204"},{"issue":"1","key":"10018_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0165-0327(99)00092-0","volume":"58","author":"IM Anderson","year":"2000","unstructured":"Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58(1):19\u201336. https:\/\/doi.org\/10.1016\/s0165-0327(99)00092-0.","journal-title":"J Affect Disord"},{"issue":"7","key":"10018_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5414\/cp201500","volume":"49","author":"Y-E Jung","year":"2011","unstructured":"Jung Y-E, Jun T-Y, Kim K-S, et al. Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine and venlafaxine, in Korean patients with major depressive disorder. Int J Clin Pharmacol Ther. 2011;49(7):437\u201343. https:\/\/doi.org\/10.5414\/cp201500.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"10018_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjmed.2017.07.025","volume":"131","author":"S Farmand","year":"2018","unstructured":"Farmand S, Lindh JD, Calissendorff J, et al. Differences in associations of antidepressants and hospitalization due to hyponatremia. Am J Med. 2018;131(1):56\u201363. https:\/\/doi.org\/10.1016\/j.amjmed.2017.07.025.","journal-title":"Am J Med"},{"issue":"7\/8","key":"10018_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1345\/aph.1A337","volume":"36","author":"ZH Arinzon","year":"2002","unstructured":"Arinzon ZH, Lehman YA, Fidelman ZG, et al. Delayed recurrent SIADH associated with SSRIs. Ann Pharmacother. 2002;36(7\/8):1175\u20137. https:\/\/doi.org\/10.1345\/aph.1A337.","journal-title":"Ann Pharmacother."},{"issue":"4 Pt 2","key":"10018_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/15622970701687311","volume":"10","author":"K Koelkebeck","year":"2009","unstructured":"Koelkebeck K, Domschke K, Zwanzger E, et al. A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine. World J Biol Psychiatry. 2009;10(4 Pt 2):609\u201311. https:\/\/doi.org\/10.1080\/15622970701687311.","journal-title":"World J Biol Psychiatry"},{"key":"10018_CR7","unstructured":"Kronenberg HM, Shlomo Melmed MD, et al. Williams Textbook of Endocrinology. 10th ed: New York: Elsevier.\u00a02002."},{"issue":"5","key":"10018_CR8","first-page":"597","volume":"55","author":"C Fonzo-Christe","year":"2000","unstructured":"Fonzo-Christe C, Vogt N. Susceptibility of the elderly patient to hyponatremia induced by selective serotonin reuptake inhibitors. Therapie. 2000;55(5):597\u2013604.","journal-title":"Therapie"},{"key":"10018_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2125.1999.00872.x","volume":"47","author":"TJ Wilkinson","year":"1999","unstructured":"Wilkinson TJ, Begg EJ, Winter AC, et al. Incidence and risk factors for hyponatraemia follow ing treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol. 1999;47:211\u20137. https:\/\/doi.org\/10.1046\/j.1365-2125.1999.00872.x.","journal-title":"Br J Clin Pharmacol"},{"key":"10018_CR10","doi-asserted-by":"publisher","unstructured":"Jannini TB, Lorenzo GD, Bianciardi E, et al. Off-label uses of selective serotonin reuptake inhibitors (SSRIs). Curr Neuropharmacol.\u00a02021;20(4):693\u2013712. https:\/\/doi.org\/10.2174\/1570159X19666210517150418.","DOI":"10.2174\/1570159X19666210517150418"},{"key":"10018_CR11","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/aitc201508040","volume":"163","author":"DA Henry","year":"2014","unstructured":"Henry DA. Hyponatremia. Ann Intern Med. 2014;163:ITC1\u201319. https:\/\/doi.org\/10.7326\/aitc201508040.","journal-title":"Ann Intern Med."},{"key":"10018_CR12","unstructured":"Anderson M, Heistad D, Kerber RE. Manual of Heart Failure: JP Medical Ltd.\u00a02014."},{"issue":"4","key":"10018_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-2005-871243","volume":"38","author":"K Miehle","year":"2005","unstructured":"Miehle K, Paschke R, Koch CA. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): A case report. Pharmacopsychiatry. 2005;38(4):181\u20132. https:\/\/doi.org\/10.1055\/s-2005-871243.","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10018_CR14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/archinte.1995.00430090099011","volume":"155","author":"EL Siegler","year":"1995","unstructured":"Siegler EL, Tamres D, Berlin JA, et al. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med. 1995;155(9):953\u20137. https:\/\/doi.org\/10.1001\/archinte.1995.00430090099011.","journal-title":"Arch Intern Med"},{"key":"10018_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/gps.591","volume":"17","author":"D Kirby","year":"2002","unstructured":"Kirby D, Harrigan S, Ames D. Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and velafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry. 2002;17:231\u20137. https:\/\/doi.org\/10.1002\/gps.591.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10018_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1745-7599.2007.00280.x","volume":"20","author":"SK Wright","year":"2008","unstructured":"Wright SK, Schroeter S. Hyponatremia as a complication of selective serotonin reuptake inhibitors. J Am Acad Nurse Pract. 2008;20(1):47\u201351. https:\/\/doi.org\/10.1111\/j.1745-7599.2007.00280.x.","journal-title":"J Am Acad Nurse Pract"},{"issue":"9","key":"10018_CR17","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1345\/aph.1G293","volume":"40","author":"S Jacob","year":"2006","unstructured":"Jacob S, Spinier SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40(9):1618\u201322. https:\/\/doi.org\/10.1345\/aph.1G293.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10018_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4088\/JCP.14m09580","volume":"77","author":"CW-S Lee","year":"2016","unstructured":"Lee CW-S, Lin C-L, Sung F-C, et al. Antidepressant treatment and risk of dementia: a population-based, retrospective case-control study. J Clin Psychiatry. 2016;77(1):117\u201322. https:\/\/doi.org\/10.4088\/JCP.14m09580.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10018_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.ajkd.2016.08.020","volume":"69","author":"S Gandhi","year":"2017","unstructured":"Gandhi S, Shariff SZ, Al-Jaishi A, et al. Second-generation antidepressants and hyponatremia risk: A population-based cohort study of older adults. Am J Kidney Dis. 2017;69(1):87\u201396. https:\/\/doi.org\/10.1053\/j.ajkd.2016.08.020.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10018_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/00048679809062743","volume":"32","author":"J Strachan","year":"1998","unstructured":"Strachan J, Shepherd J. Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors. Aust N Z J Psychiatry. 1998;32(2):295\u20138. https:\/\/doi.org\/10.3109\/00048679809062743.","journal-title":"Aust N Z J Psychiatry"},{"key":"10018_CR21","doi-asserted-by":"publisher","unstructured":"Shysh AC, Ismail Z, Sidhu D, et al. Factors associated with hyponatremia in patients newly prescribed citalopram: A retrospective observational study. Drugs Real World Outcomes. 2021;8(4):555\u2013563 https:\/\/doi.org\/10.1007\/s40801-021-00257-4.","DOI":"10.1007\/s40801-021-00257-4"},{"issue":"6","key":"10018_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","volume":"55","author":"L De Picker","year":"2014","unstructured":"De Picker L, Van Den Eede F, Dumont G, et al. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics. 2014;55(6):536\u201347. https:\/\/doi.org\/10.1016\/j.psym.2014.01.010.","journal-title":"Psychosomatics"},{"issue":"3","key":"10018_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/ndt\/gfs038","volume":"27","author":"CP Kovesdy","year":"2012","unstructured":"Kovesdy CP. Significance of hypo- and hypernatremia in chronic kidney disease. Nephrol Dial Transplant. 2012;27(3):891\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfs038.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10018_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.111.065391","volume":"125","author":"CP Kovesdy","year":"2012","unstructured":"Kovesdy CP, Lott EH, Lu JL, et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012;125(5):677\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.065391.","journal-title":"Circulation"},{"issue":"8","key":"10018_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1177\/02698811211001082","volume":"35","author":"B Mannheimer","year":"2021","unstructured":"Mannheimer B, Falhammar H, Calissendorff J, et al. Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia. J Psychopharmacol. 2021;35(8):928\u201333. https:\/\/doi.org\/10.1177\/02698811211001082.","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10018_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/00002826-200009000-00005","volume":"23","author":"MC Catalano","year":"2000","unstructured":"Catalano MC, Catalano G, Kanfer SN, et al. The effect of sertraline on routine blood chemistry values. Clin Neuropharmacol. 2000;23(5):267\u201370. https:\/\/doi.org\/10.1097\/00002826-200009000-00005.","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10018_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000124925","volume":"47","author":"MS Brownfield","year":"1988","unstructured":"Brownfield MS, Greathouse J, Lorens SA, et al. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology. 1988;47(4):277\u201383. https:\/\/doi.org\/10.1159\/000124925.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10018_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0014-4886(90)90042-q","volume":"110","author":"SF Leibowitz","year":"1990","unstructured":"Leibowitz SF, Eidelman D, Suh JS, et al. Mapping study of noradrenergic stimulation of vasopressin release. Exp Neurol. 1990;110(3):298\u2013305. https:\/\/doi.org\/10.1016\/0014-4886(90)90042-q.","journal-title":"Exp Neurol"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-023-10018-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11126-023-10018-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-023-10018-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T10:06:19Z","timestamp":1688205979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11126-023-10018-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10018"],"URL":"https:\/\/doi.org\/10.1007\/s11126-023-10018-x","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"5 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Clinical Research Ethics Board of Beijing Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}